Search for: "Astra Zeneca Pharmaceutical Company" Results 1 - 20 of 30
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2010, 10:40 am
Mega drug company Astra Zeneca has agreed to pay $ 520 million to resolve charges that it unlawfully pushed a powerful anti-psychotic medication to treat medical problems that it was never approved for the Food and Drug Administration. [read post]
31 Jan 2013, 3:44 am by Ben Vernia
Astra-Zeneca Pharmaceuticals LP, a whistleblower case brought by a former vice president of pharmaceutical contracting for the pharmacy benefits manager (PBM), Medco. [read post]
20 Oct 2009, 1:15 am
The US Attorney’s office in New Hampshire announced yesterday the settlement of a qui tam alleging that four pharmaceutical companies - Mylan Pharmaceuticals, UDL Laboratories, Aztra-Zeneca Pharmaceuticals, and Ortho-McNeill - mischaracterized their prescription drugs to state Medicaid programs. [read post]
28 Apr 2010, 7:14 am by Mark Zamora
Before approving a drug, the FDA must determine that the drug is safe and effective for the use proposed by the company. [read post]
15 Apr 2008, 8:09 pm
  This conference is billed as the "must attend" meeting for in-house counsel in pharmaceutical companies and lawyers in private practice who specialize in the life sciences. [read post]
29 Oct 2006, 7:43 pm
Harper KV Pharmaceutical Company recently filed a citizen petition asking the FDA to relist U.S. [read post]
13 Jun 2023, 8:00 am by Eugene Volokh
Astra Zeneca Pharmaceuticals, LP, (MN App., June 12, 2023), was the only one of the four cases published as a precedential decision. [read post]
6 Oct 2009, 4:00 am
AstraZeneca was formed through a 1999 merger between Britain's Zeneca Group PLC and Sweden's Astra AB, the parent of Astra USA.Corporate boards face mounting pressure to crack down on executives who breach their fiduciary duty, said Thomas C. [read post]
16 Sep 2011, 11:02 am by eithurburn@getnicklaw.com
  The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
19 Apr 2010, 11:39 am by Phillips & Cohen
It details the activities and successes of NY's MFCU.The report highlights Operation Home Alone, an investigation of corruption in the home care industry; settlements with several pharmaceutical companies, including Eli Lilly, Pfizer, Mylan Pharmaceuticals, Astra Zeneca, and Aventis for off-label marketing, kickbacks, misreporting prices, and other fraud; nursing home fraud investigations; and other types of program fraud. [read post]
11 May 2010, 1:10 pm by FDABlog HPM
  To any pharmaceutical company that included, as part of its evaluation of its promotional activities,  whether or not the material would be a “leave-behind” -  this may be a game changer. [read post]
8 May 2012, 9:53 am by jleaming@acslaw.org
Astra Zeneca, Johnson & Johnson and Pfizer have all paid hefty fines following allegations of marketing derelictions. read more [read post]
4 Apr 2012, 2:30 am
With so many popular antidepressants' exclusivity patents getting ready to expire soon and more recent drugs to hit the market like Astra Zeneca failing, many drug manufacturers just lost interest in developing newer drugs. [read post]
13 Jun 2023, 4:05 am by Howard Friedman
Astra Zeneca Pharmaceuticals, LP, (MN App., June 12, 2023), was the only one of the four cases published as a precedential decision. [read post]
3 Jun 2020, 1:06 am by Roya Ghafele (OxFirst)
In the UK the government bets on a collaboration between Oxford University and the British Pharmaceutical Company Astra Zeneca. [read post]
13 Jul 2021, 7:18 am by Neil Wilkof
The Oxford-Astra Zeneca vaccine, the J&J vaccine, the Novovax vaccine and the Russian Sputnik vaccine have all been licensed to Indian companies for manufacture and distribution within India and, in some cases, for the rest of the developing world. [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
28 Nov 2008, 12:49 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research Foundation (WARF) stem cell application (IAM) (IPKat) (EPO) European Commission releases… [read post]